Technical Analysis for ARGX - argenx SE

Grade Last Price % Change Price Change
grade B 66.33 1.61% 1.05
ARGX closed up 1.61 percent on Friday, January 19, 2018, on 63 percent of normal volume.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Very Strong N/A Up Up
See historical ARGX trend table...

Date Alert Name Type % Chg
Jan 19 Wide Bands Range Expansion 0.00%
Jan 18 1,2,3 Pullback Bullish Bullish Swing Setup 1.61%
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.61%
Jan 18 Narrow Range Bar Range Contraction 1.61%
Jan 18 Wide Bands Range Expansion 1.61%
Jan 18 Down 3 Days in a Row Weakness 1.61%
Jan 18 Gapped Down Weakness 1.61%
Jan 17 Narrow Range Bar Range Contraction -1.98%
Jan 17 NR7 Range Contraction -1.98%
Jan 17 Wide Bands Range Expansion -1.98%

Older signals for ARGX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
argenx SE, a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company’s lead clinical stage product candidates include ARGX-113, a product in Phase 2 clinical trials for the treatment of autoimmune diseases, including myasthenia gravis and immune thrombocytopenia; and ARGX-110, which is in Phase 1/2 clinical trials for the treatment of hematological cancers, such as T-cell lymphoma, acute myeloid leukemia, and myelodysplastic syndrome. It is also developing ARGX-111 to treat solid tumors with MET amplification; ARGX-109 for the treatment of rheumatoid arthritis; ARGX-112 to treat skin inflammation; ARGX-115, a cancer immunotherapy-focused product candidate; and ARGX-116 for the treatment of dyslipidemia. The company has license and collaboration agreements with AbbVie S.Á.R.L.; Bird Rock Bio, Inc.; LEO Pharma A/S; Shire International GmbH; and Bayer AG. argenx SE was founded in 2008 and is based in Breda, the Netherlands.
Is ARGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 71.4
52 Week Low 17.33
Average Volume 286,504
200-Day Moving Average 0.0
50-Day Moving Average 45.1824
20-Day Moving Average 62.7455
10-Day Moving Average 63.941
Average True Range 4.1245
ADX 55.39
+DI 37.65
-DI 13.02
Chandelier Exit (Long, 3 ATRs ) 59.0265
Chandelier Exit (Short, 3 ATRs ) 66.3035
Upper Bollinger Band 69.9061
Lower Bollinger Band 55.5849
Percent B (%b) 0.75
BandWidth 22.824266
MACD Line 5.6582
MACD Signal Line 6.2904
MACD Histogram -0.6322
Fundamentals Value
Market Cap 1.78 Billion
Num Shares 26.9 Million
EPS -1.27
Price-to-Earnings (P/E) Ratio -52.23
Price-to-Sales 15.41
Price-to-Book 3.49
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.58
Resistance 3 (R3) 71.50 69.68 70.71
Resistance 2 (R2) 69.68 68.34 69.72 70.41
Resistance 1 (R1) 68.00 67.51 68.84 68.08 70.12
Pivot Point 66.18 66.18 66.60 66.22 66.18
Support 1 (S1) 64.50 64.84 65.34 64.58 62.54
Support 2 (S2) 62.68 64.01 62.72 62.25
Support 3 (S3) 61.00 62.68 61.96
Support 4 (S4) 61.08